Molecular Dynamics Simulations and Structural Analysis of Giardia duodenalis 14-3-3 Protein-Protein Interactions

Giardiasis is a gastrointestinal diarrheal illness caused by the protozoan parasite Giardia duodenalis, which affects annually over 200 million people worldwide. The limited antigiardial drug arsenal and the emergence of clinical cases refractory to standard treatments dictate the need for new chemotherapeutics. The 14-3-3 family of regulatory proteins, extensively involved in protein-protein interactions (PPIs) with pSer/pThr clients, represents a highly promising target. Despite homology with human counterparts, the single 14-3-3 of G. duodenalis (g14-3-3) is characterized by a constitutive phosphorylation in a region critical for target binding, thus affecting the function and the conformation of g14-3-3/clients interaction. However, to approach the design of specific small molecule modulators of g14-3-3 PPIs, structural elucidations are required. Here, we present a detailed computational and crystallographic study exploring the implications of g14-3-3 phosphorylation on protein structure and target binding. Self-Guided Langevin Dynamics and classical molecular dynamics simulations show that phosphorylation affects locally and globally g14-3-3 conformation, inducing a structural rearrangement more suitable for target binding. Profitable features for g14-3-3/clients interaction were highlighted using a hydrophobicity-based descriptor to characterize g14-3-3 client peptides. Finally, the X-ray structure of g14-3-3 in complex with a mode-1 prototype phosphopeptide was solved and combined with structure-based simulations to identify molecular features relevant for clients binding to g14-3-3. The data presented herein provide a further and structural understanding of g14-3-3 features and set the basis for drug design studies.

[1]  Artur Gieldon,et al.  Theoretical study on binding of S100B protein , 2007, Journal of molecular modeling.

[2]  S. Jois,et al.  Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors , 2015, Molecules.

[3]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[4]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[5]  L. Robertson,et al.  Giardiasis: the ever-present threat of a neglected disease. , 2010, Infectious disorders drug targets.

[6]  A. Buret,et al.  Extra-intestinal and long term consequences of Giardia duodenalis infections. , 2013, World journal of gastroenterology.

[7]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[8]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[9]  D. Case,et al.  Langevin modes of macromolecules: Applications to crambin and DNA hexamers , 1990, Biopolymers.

[10]  M. Peggie,et al.  14‐3‐3s regulate fructose‐2,6‐bisphosphate levels by binding to PKB‐phosphorylated cardiac fructose‐2,6‐bisphosphate kinase/phosphatase , 2003, The EMBO journal.

[11]  J Pohl,et al.  14-3-3ζ Binds a Phosphorylated Raf Peptide and an Unphosphorylated Peptide via Its Conserved Amphipathic Groove* , 1998, The Journal of Biological Chemistry.

[12]  S. M. Fayaz,et al.  Modelling the molecular mechanism of protein–protein interactions and their inhibition: CypD–p53 case study , 2015, Molecular Diversity.

[13]  Jean-Luc Poyet,et al.  Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.

[14]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[15]  F. Khuri,et al.  14-3-3 proteins as potential therapeutic targets. , 2011, Seminars in cell & developmental biology.

[16]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[17]  Bernard R Brooks,et al.  Efficient and Unbiased Sampling of Biomolecular Systems in the Canonical Ensemble: A Review of Self-Guided Langevin Dynamics. , 2012, Advances in chemical physics.

[18]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[19]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Steitz,et al.  Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. , 1986, Annual review of biophysics and biophysical chemistry.

[21]  M. Skwarczynska,et al.  Structure of a 14-3-3σ-YAP phosphopeptide complex at 1.15 A resolution. , 2010, Acta crystallographica. Section F, Structural biology and crystallization communications.

[22]  C. Supuran,et al.  Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing. , 2015, ACS chemical biology.

[23]  Joseph Avruch,et al.  Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. , 2003, Molecular biology of the cell.

[24]  L. Rezabkova,et al.  Structural Basis for the 14-3-3 Protein-dependent Inhibition of the Regulator of G Protein Signaling 3 (RGS3) Function* , 2011, The Journal of Biological Chemistry.

[25]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[26]  T. Obsil,et al.  Structural basis of 14-3-3 protein functions. , 2011, Seminars in cell & developmental biology.

[27]  M. Botta,et al.  Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy. , 2011, Current pharmaceutical design.

[28]  L. Di Marcotullio,et al.  Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors , 2014, The EMBO journal.

[29]  J Günter Grossmann,et al.  Structural basis for protein–protein interactions in the 14-3-3 protein family , 2006, Proceedings of the National Academy of Sciences.

[30]  C. Luchinat,et al.  Fragment Docking to S100 Proteins Reveals a Wide Diversity of Weak Interaction Sites , 2007, ChemMedChem.

[31]  M. Botta,et al.  A New Nonpeptidic Inhibitor of 14-3-3 Induces Apoptotic Cell Death in Chronic Myeloid Leukemia Sensitive or Resistant to Imatinib , 2011, Journal of Pharmacology and Experimental Therapeutics.

[32]  H. Gohlke,et al.  Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method , 2012, Molecular informatics.

[33]  M. Yaffe,et al.  The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[34]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[35]  C. Ottmann,et al.  Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction. , 2014, Angewandte Chemie.

[36]  C. Ottmann,et al.  Discovery of 14‐3‐3 Protein–Protein Interaction Inhibitors that Sensitize Multidrug‐Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 , 2014, ChemMedChem.

[37]  Fabrizio Manetti,et al.  Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. , 2010, Bioorganic & medicinal chemistry letters.

[38]  P A Kollman,et al.  Continuum solvent studies of the stability of RNA hairpin loops and helices. , 1998, Journal of biomolecular structure & dynamics.

[39]  Jolanta Grembecka,et al.  Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? , 2015, Immunological reviews.

[40]  Fabrizio Manetti,et al.  Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators , 2011, J. Chem. Inf. Model..

[41]  Ujjwal Maulik,et al.  A review of in silico approaches for analysis and prediction of HIV-1-human protein-protein interactions , 2015, Briefings Bioinform..

[42]  S. Camerini,et al.  Interkingdom Complementation Reveals Structural Conservation and Functional Divergence of 14-3-3 Proteins , 2013, PloS one.

[43]  B. Brooks,et al.  Langevin dynamics of peptides: The frictional dependence of isomerization rates of N‐acetylalanyl‐N′‐methylamide , 1992, Biopolymers.

[44]  Maurizio Botta,et al.  Small molecules modulation of 14-3-3 protein-protein interactions. , 2013, Drug discovery today. Technologies.

[45]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[46]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[47]  S. Huber,et al.  Divalent cations and polyamines bind to loop 8 of 14-3-3 proteins, modulating their interaction with phosphorylated nitrate reductase. , 2002, The Plant journal : for cell and molecular biology.

[48]  M. Crescenzi,et al.  The Giardia duodenalis 14-3-3 Protein Is Post-translationally Modified by Phosphorylation and Polyglycylation of the C-terminal Tail* , 2006, Journal of Biological Chemistry.

[49]  M. Yaffe,et al.  A Structural Basis for 14-3-3σ Functional Specificity*♦ , 2005, Journal of Biological Chemistry.

[50]  H. Hermeking,et al.  The crystal structure of the non-liganded 14-3-3σ protein: insights into determinants of isoform specific ligand binding and dimerization , 2005, Cell Research.

[51]  C. Ottmann,et al.  Molecular tweezers modulate 14-3-3 protein-protein interactions. , 2013, Nature chemistry.

[52]  Anselm H. C. Horn,et al.  AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine , 2006, Journal of molecular modeling.

[53]  Fabrizio Manetti,et al.  Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case. , 2011, Bioorganic & medicinal chemistry letters.

[54]  Peter A. Kollman,et al.  Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models , 2001 .

[55]  M. Lalle.  Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. , 2010, Infectious disorders drug targets.

[56]  Kamyar Hadian,et al.  Protein–protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays , 2014, Expert opinion on drug discovery.

[57]  M. Crescenzi,et al.  Interaction network of the 14-3-3 protein in the ancient protozoan parasite Giardia duodenalis. , 2012, Journal of proteome research.

[58]  Meng Wu,et al.  C‐terminal binding: An expanded repertoire and function of 14‐3‐3 proteins , 2006, FEBS letters.

[59]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[60]  A. Via,et al.  The Crystal Structure of Giardia duodenalis 14-3-3 in the Apo Form: When Protein Post-Translational Modifications Make the Difference , 2014, PloS one.

[61]  Jianyin Shao,et al.  Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms. , 2007, Journal of chemical theory and computation.

[62]  B. Brooks,et al.  Self-guided Langevin dynamics simulation method , 2003 .

[63]  M. Crescenzi,et al.  Involvement of 14-3-3 protein post-translational modifications in Giardia duodenalis encystation. , 2010, International journal for parasitology.